Langsung ke konten

Thalasemia Beta Intermedia dan Minor

Perawatan Pendukung

Kelasi Besi

Iron out for nontransfused thalassemia. (terbuka di window baru)

Marks PW.

Sumber‎: Blood 2012;120(5):928-9.

Index‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (terbuka di window baru)

Iron overload in β-thalassemia intermedia: an emerging concern. (terbuka di window baru)

Musallam KM, Cappellini MD, Taher AT.

Sumber‎: Curr Opin Hematol 2013;20(3):187-92.

Index‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (terbuka di window baru)

Suplemen Makanan dan Terapi Pendukung Lain

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (terbuka di window baru)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Sumber‎: Blood 2012;120(7):1531-2.

Index‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (terbuka di window baru)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (terbuka di window baru)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Sumber‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Index‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (terbuka di window baru)

Therapeutic roles of curcumin: lessons learned from clinical trials. (terbuka di window baru)

Gupta SC, Patchva S, Aggarwal BB.

Sumber‎: AAPS J 2013;15(1):195-218.

Index‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (terbuka di window baru)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (terbuka di window baru)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Sumber‎: J Med Assoc Thai 2012;95(1):29-36.

Index‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (terbuka di window baru)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (terbuka di window baru)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Sumber‎: Am J Hematol 2013;88(6):503-6.

Index‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (terbuka di window baru)